Individualized Stent for Tracheal Fistula Complicating Tracheostomy Following Esophagectomy Authors: Xiaerbate Zakeerjiang, Yu ChenYi, Liu Bing, Liu Bin, Liu YaTing, Yuan YiFei Published: 2026 ABSTRACT ABSTRACTDelayed‐onset tracheal fistula following esophagectomy with concurrent tracheostomy is rare and poses diagnostic challenges. A 79‐year‐old female patient with oesophageal squamous cell carcinoma (ESCC) developed a tracheal fistula following esophagectomy and tracheostomy. Repeated bronchoscopies via the tracheostoma failed to visualize the fistula orifice; the diagnosis was confirmed by computed tomography (CT) with oral contrast medium and complete tracheal inspection following temporary removal of the tracheostomy tube. A patient‐specific, fully covered self‐expandable metallic stent (FCSEMS) was implanted under endoscopic guidance. At 53 days of follow‐up, the stent remained well‐positioned without aspiration recurrence. The patient ultimately succumbed to distant tumour metastasis and multidrug‐resistant bacterial infection. Complete tracheobronchoscopy following temporary decannulation and CT with oral contrast medium facilitates the diagnosis of tracheal fistula. Individualized covered stenting achieves satisfactory fistula occlusion, thereby providing valuable clinical insights for the management of similar complex cases.Keywords: bronchoscopy, customized stent, tracheal fistula, tracheostomy Introduction Oesophageal cancer is a common malignant tumour worldwide, and surgery remains the cornerstone of curative treatment. Postoperative anastomotic leakage complicates approximately 8.2%–15% of cases. A tracheal fistula is an abnormal communication formed between the trachea and adjacent anatomical structures. In some cases, a tracheal fistula may develop secondary to tracheal wall invasion caused by mediastinitis complicating postoperative anastomotic leakage, rather than direct tumour invasion [1, 2]. Currently, the main therapeutic strategies for tracheal fistula include surgical repair and stent placement. The selection of treatment should be individualized based on the underlying aetiology, the patients' anaesthetic risk profile, and other relevant clinical factors. In recent years, the widespread application of tracheal stenting has achieved favourable clinical outcomes in most patients [3, 4, 5]. However, in certain cases—especially in patients with tracheal fistula complicated by preexisting tracheostomy—conventional straight or Y‐shaped stents are prone to malpositioning, inadequate fistula sealing, and premature migration. Therefore, for such patients, the available options include 3D‐customized stents or intraoperative individualized trimming of stents [6, 7, 8]. This case report describes the diagnosis and treatment course of a patient with tracheal fistula complicated by tracheotomy following oesophageal carcinoma surgery, who underwent tracheal fistula occlusion with a customized intratracheal covered metal stent. The purpose of this report is to provide empirical insights for the diagnosis and management of tracheal fistula complicated by tracheotomy. Case Report A 79‐year‐old female patient presented to our hospital on April 15, 2025, with a 1‐month history of progressive dysphagia. Contrast‐enhanced computed tomography (CT), upper gastrointestinal endoscopy, and biopsy were performed, which established a diagnosis of oesophageal squamous cell carcinoma (cT3N0M0) (Figure 1A). Her only comorbidity was hypertension. On postoperative day 3 (POD 3) following radical esophagectomy, the patient developed a new‐onset pulmonary infection (Figure 1B). Despite aggressive anti‐infective therapy and endotracheal intubation, the pulmonary infection remained refractory to treatment. On POD 16, the patient progressed to acute respiratory failure (ARF), requiring continued mechanical ventilation. A chest anteroposterior X‐ray was obtained, which revealed right‐sided pneumothorax (Figure 1C). Elevated pleural fluid amylase levels and gastroscopic identification of an anastomotic leak approximately 25 cm from the nares supported the diagnosis of esophagopleural fistula (EPF), with a suspected concurrent tracheopleural fistula (TPF). However, repeated bronchoscopies performed via the tracheostomy failed to identify any tracheal fistulous tract. Radiologic and endoscopic findings, and customized tracheal stent design in a 79‐year‐old woman with a occult tracheal Fistula following esophagectomy. (A) Esophagoscopy shows an intraluminal oesophageal mass (black arrows) with oozing blood on the surface, through which the endoscope could not pass. (B) Axial computed tomography (CT) scan of the chest obtained on postoperative day (POD) 3 demonstrates new‐onset bilateral pulmonary infection (black arrows). (C) Chest radiograph shows a right‐sided pneumothorax, with the pleural line visible (black arrow). (D) Axial CT scan of the chest obtained on POD 37 after oral contrast administration demonstrates contrast extravasation into the right pleural cavity via an abnormal communication between the trachea and the pleural space (white arrow). (E) Axial CT scan of the neck obtained on POD 37 after oral contrast administration demonstrates an abnormal communication between the trachea and oesophagus consistent with TEF (white arrow). (F) Schematic diagram of customized tracheal stent. The stent is integrated with an overall length of 80 mm. The upper smaller segment has a diameter (d1) of 18 mm and length of 25 mm, with a 15‐mm circular side opening located 10 mm distal to the upper edge of the stent. The lower larger segment has a diameter (d2) of 22 mm and a length of 55 mm. (G) Bronchoscopic image obtained immediately after stent placement, confirming proper position of the customized stent. After comprehensive evaluation, the patient was deemed unable to tolerate redo oesophageal surgery. Given the small size of the anastomotic fistula, conservative management was selected for the fistula, including indwelling thoracic drainage, replacement of the gastric tube with a jejunal tube, and targeted anti‐infection therapy. The patient's pulmonary infection persisted, and multiple extubation attempts failed. Therefore, tracheotomy was performed at the level of the 2nd‐3rd tracheal rings on (POD 26). To assess the healing status of the anastomotic fistula, the patient underwent chest CT with oral contrast medium on POD 37, and the results revealed communication between the oesophagus, trachea, and thoracic cavity (Figure 1D,E). On POD 38, during bronchoscopy, after removal of the tracheostomy tube, a fistulous tract with a length of approximately 1.5 cm was identified in the membranous portion of the mid‐trachea, approximately 7 cm from the glottis. Given the patient's poor overall condition, surgical repair of the fistulous tract was deemed not feasible. Therefore, in addition to conservative treatments including continuous thoracic drainage, etiological findings‐based anti‐infection therapy, and combined enteral and parenteral nutritional support, elective tracheal stent placement was selected to occlude the fistulous tract. The patient was in a tracheotomized state, and the location of the tracheal fistulous tract overlapped with the area covered by the tracheostomy tube. Due to the potential risks of migration or inadequate sealing with conventional straight stents, and considering that the fistulous tract was located relatively distant from the carina, the use of a Y‐shaped stent was not deemed suitable. Therefore, after thorough evaluation, a customized covered metal tracheal stent was selected based on the patient's anatomical characteristics (Figure 1F). The total length of the stent was 80 mm, consisting of an upper small segment with a diameter (d1) of 18 mm and a length of 25 mm, and a lower large segment with a diameter (d2) of 22 mm and a length of 55 mm. A circular fenestration with a diameter of 15 mm was located on the lateral side of the upper small segment, with the upper edge of the fenestration 10 mm away from the upper edge of the stent. On POD 45, when the patient's vital signs were stable, the tracheostomy tube was removed. A bronchoscope was then inserted via the nasal cavity; after thoroughly aspirating the secretions and reconfirming the location and size of the fistulous tract (i.e., in the membranous portion of the mid‐trachea, approximately 7 cm from the glottis and 1.5 cm in length), a stent was implanted into the trachea under the guidance of a pulmonary guidewire. The stent was well‐positioned and fully expanded, with adequate coverage of the fistulous tract, and the fenestration of the stent was well‐apposed to the tracheostomy site. After successful stent implantation, the tracheostomy tube was reinserted (Figure 1G). A bronchoscopy performed on POD 98 (53 days after stent placement) confirmed proper positioning of the endotracheal stent, with no recurrence of aspiration symptoms observed in the patient. However, the patient ultimately died of distant tumour metastasis and infection. Discussion Oesophageal carcinoma is a common malignant tumour worldwide, and multimodal treatment strategies including surgery are now widely adopted; however, some patients may develop postoperative complications [2, 9, 10]. Anastomotic fistula is a severe postoperative complication following oesophageal carcinoma surgery, with an incidence ranging from 8.2% to 15% [1, 11]. Treatment options for closing or covering the fistula can be selected based on factors including its location, size, symptom severity, and the presence of ischemia and necrosis in the tissues surrounding the fistula, along with the removal of fluid or food that has entered the thoracic cavity through the fistula to control inflammation [12]. Invasion of the tracheal wall by oesophageal tumours or mediastinal inflammation can lead to necrosis and perforation, potentially resulting in complications including tracheopleural or esophagotracheal fistulas. These fistulas carry a substantial risk of severe aspiration pneumonia or life‐threatening asphyxiation secondary to tracheal obstruction by ingested material [13]. Meanwhile, postoperative pulmonary infection may result in delayed anastomotic healing through local tissue hypoxia and decreased perfusion and constitutes a well‐recognized risk factor for anastomotic fistula [14]. In this case, the patient presented with symptoms of pulmonary infection on postoperative day POD3. However, by POD8, the pleural fluid amylase level remained within normal limits, only a small volume of serosanguinous fluid was drained from the thoracic cavity, and repeated chest CT and X‐ray imaging revealed no evidence of aspiration pneumonia or pneumothorax. Moreover, bronchoscopy via the tracheostomy site revealed no tracheal fistula. Consequently, an anastomotic leak or tracheal fistula was not suspected at that stage, and management was limited to symptomatic treatment for a presumed uncomplicated pulmonary infection, including antimicrobial therapy and endotracheal intubation. Despite these measures, the pulmonary infection progressed, leading to respiratory failure with a poor response to antibiotic therapy. A re‐examination revealed an elevation in pleural fluid amylase, suggesting the possible presence of an anastomotic fistula. Subsequent gastroscopy confirmed the diagnosis of an anastomotic fistula, but multiple bronchoscopies via the tracheostomy site revealed no tracheal fistula. The patient's chest X‐ray showed persistent right‐sided pneumothorax. Given the absence of a history of emphysema and chest trauma during hospitalization, a concurrent tracheal fistula was still highly suspected. At this time, the fistula had gradually expanded and would eventually reach a length of approximately 15 mm when definitively identified. Therefore, cervical and chest CT examinations with oral contrast medium were performed on POD37, which confirmed the presence of the tracheal fistula. However, as no tissue samples were obtained from the anastomotic fistula or the tracheal fistula for pathological examination, the exact aetiology could not be determined. After identifying the approximate location of the tracheal fistula based on the CT results, during bronchoscopy performed on POD38 with the tracheostomy tube removed, a fistula approximately 1.5 cm in length was visualized at the site previously covered by the tube. This case delivers an important clinical lesson that routine bronchoscopy through the tracheostomy opening may fail to detect tracheal defects covered by the tracheostomy cannula. During bronchoscopy, either deflating the tube cuff to fully expose the tracheal mucosa or temporarily removing the tracheostomy cannula is critical for achieving adequate visualization of the entire tracheal wall and preventing missed diagnoses, even in patients with an established tracheostomy receiving mechanical ventilation. Delayed recognition allows the fistula to enlarge to a considerable size, which substantially increases the risks of severe infection and respiratory compromise. Meanwhile, CT can also be used to assess the relationship between surrounding tissues and associated complications [15]. A multicenter retrospective study demonstrated that the mortality rate of patients with bronchopleural fistula (BPF) complicating thoracic surgery after surgical or endoscopic treatment is as high as 58.0%, and the BPF‐related mortality rate reaches 48.9% [16]. After confirming the diagnosis of a tracheal fistula, either stent placement or surgical treatment should be selected based on the patient's condition. Compared with active treatment, conservative treatment alone is associated with a higher in‐hospital mortality rate [17]. For high‐risk patients with malignant tracheal fistula and an expected survival time of less than 6 months, or elderly patients with severe infections, stent placement is recommended as the first‐line treatment. For benign tracheal fistulas with controlled infection or giant tracheal fistulas, surgical treatment is preferred. If stent placement fails, second‐stage surgery may be performed if necessary [18]. Clinically commonly used stents include metal stents, silicone stents, and covered metal stents. Common covered metal stents consist of a framework (titanium‐nickel alloy stent), an inner covering membrane, and an outer covering membrane. Based on the patient's condition, straight stents, Y‐shaped stents, T‐shaped stents, dumbbell‐shaped stents, etc., can be selected. Alternatively, customized stents or intraoperatively individualized trimmed stents can be used based on actual conditions [6]. The patient in this case developed a delayed tracheal fistula after thoracic surgery, with part of the fistula covered by the tracheostomy tube. If a straight stent had been used, complications such as stent displacement or poor wall apposition might have occurred. Therefore, a covered metal stent suitable for the patient's tracheal anatomical structure was selected. This patient had undergone weaning trials before stent placement and could tolerate ventilator‐free periods of more than 30 min. In addition, our team is highly experienced in stent deployment and can perform the procedure expeditiously. Therefore, temporary removal of the tracheostomy tube was safe in this case. Nevertheless, direct removal of the tracheostomy tube carries risks such as hypoxia and asphyxia in patients with unstable vital signs. For such patients, bronchoscopy can be performed via the oral route after cuff deflation. After stent implantation, the patient's pleural effusion and pneumothorax were significantly reduced compared with those before implantation. Re‐examination on POD53 showed appropriate positioning of the endotracheal stent, and the patient exhibited no recurrence of aspiration symptoms, proving that the covered metal stent achieved a good therapeutic effect on the patient's tracheal fistula. However, during the observation period, the patient developed distant metastasis of oesophageal carcinoma, presented with poor nutritional status, and suffered from infections with multiple drug‐resistant bacteria (including CRAB, CRPA, and CRKP), eventually leading to death. It was not the tracheal fistula but the tumour itself that affected the patient's overall survival prognosis. This case illustrates that in complex scenarios where repeated bronchoscopy fails to detect an occult fistula, diagnostic manoeuvres such as temporary tracheostomy tube removal or CT imaging after oral contrast administration can play a critical diagnostic role and demonstrates the feasibility of deploying a customized, fully covered metal stent in a patient with a tracheostomy. It provides practical experience for managing delayed, concealed tracheal fistulas after thoracic surgery. Author Contributions Xiaerbate Zakeerjiang was responsible for information collection, research conceptualization, and manuscript writing. Liu Bing was in charge of research conceptualization and manuscript writing guidance. Xiaerbate Zakeerjiang, Yu Chenyi, Liu Bin, Liu Yating, and Yuan Yifei were responsible for information collection and manuscript revision. All authors have read and approved the final manuscript. Funding This work was supported by the 2022 Wuhan Science and Technology Bureau (KYXM2022003), NSFC‐BMGF Joint Project on Diagnostics R&D (82561128253), and Hubei Provincial Natural Science Foundation (Joint Fund), China (JCZRLH202601232). Ethics Statement This is a retrospective single case report based on routine clinical data. No experimental interventions, additional procedures, or biological sample collection for research purposes were performed. All identifying information has been anonymized. The study was conducted in accordance with the Declaration of Helsinki. Consent The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images from the patient's next of kin using the form provided by the Journal. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgements Language editing and grammatical polishing of this manuscript were assisted by ChatGPT. All intellectual content, data interpretation, clinical analysis, and final revision were completed solely by the authors. Zakeerjiang X., ChenYi Y., Bing L., Bin L., YaTing L., and YiFei Y., “Individualized Stent for Tracheal Fistula Complicating Tracheostomy Following Esophagectomy,” Respirology Case Reports 14, no. 9 (2026): e70755, 10.1002/rcr2.70755. Associate Editor: Michael Hsin Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.